A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

Curing cancer from within: The promise of cell therapy

Frontiers Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer

Study of cancer immunotherapy patients reveals markers of treatment response

Cancer, Latest News, Photos & Videos

Moffitt Cancer Center's Dr. Frederick Locke champions promising investigational cancer treatment through a local clinical trial

Natural Products in Cancer Therapy: Past, Present and Future

Wafik S. El-Deiry, MD, PhD, FACP on LinkedIn: A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating…

Lê Bui Wellness - LêClat

Cutting-edge approach to fighting deadly form of pancreatic cancer •

Revolutionizing Healthcare: Innovations in Regenerative Medicine Offer Hope

Michael Morgan on LinkedIn: Cell & Gene Therapy Manufacturing & Commercialization: US 2023

Vaibhav Bhatia on LinkedIn: This will have major implications

FDA considers first CRISPR gene editing treatment that may cure sickle cell

Priority Health Denied His Last Hope, CAR-T Cancer Treatment — ProPublica